Macrogenics Inc (NAS:MGNX)
$ 4.365 -0.755 (-14.75%) Market Cap: 273.39 Mil Enterprise Value: 170.46 Mil PE Ratio: 0 PB Ratio: 3.02 GF Score: 68/100

MacroGenics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 14, 2021 / 03:00PM GMT
Release Date Price: $20.62 (+1.28%)
Unidentified Analyst

Good morning, everyone. Welcome to the 39th Annual JPMorgan Healthcare Conference. My name is [Bader] (inaudible). I'm a member of the Healthcare Investment Banking team here at JPMorgan. Thank you for joining this next session we have with MacroGenics.

Before I hand over to our presenter, Scott Koenig, President and CEO of MacroGenics, I'd like to remind everyone that we have a Q&A session after the prepared remarks, and that you'll be able to submit questions through the blue submit a question button. So we'll commence the Q&A session in approximately 20 to 25 minutes.

And with that, I'll turn it over to Scott.

Scott Koenig
MacroGenics, Inc. - CEO, President & Director

Thank you, [Bader], and thank you for the opportunity to present at the JPMorgan Conference. I hope everyone is safe and healthy under these unusual circumstances. Slide 2, I will be making forward-looking statements during my presentation, so please refer to our SEC filings to understand the risk in investing in MacroGenics.

Slide 3.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot